The jury's still out on whether or not CBD relieves stress and anxiety.
Many people object to the added ingredients in vaccines. But pharmacists explain why those fears are unwarranted.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Aerosols of some FDA-approved food coloring could deactivate airborne viruses.
Consuming the plant can be lethal to animals and humans.
Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.
After firms add more women to their board, dangerous medical products are recalled more quickly.
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Researchers are developing a seasonal shot that blocks Lyme disease-causing bacteria from a tick.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven't been tried before.
To battle the coronavirus, strong regulatory protection from the FDA is essential.
The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.
Among the more than 20,000 drugs approved by the FDA, there may be some that can treat COVID-19. A team at the University of California, San Francisco, is identifying possible candidates.
Americans love their supplements, but some of the products are contaminated with heavy metals, bacteria and toxic fungi. The FDA has little control because of a law passed in 1994.
MDMA is better known as the party psychedelic Ecstasy or Molly. Used clinically, together with psychotherapy, it reduces symptoms of post-traumatic stress disorder, and shows promise with couples.
Researchers are looking for ways to determine who's most at risk for dementia and also ways to detect it early. A scientist who has studied low blood pressure makes a case for a link between the two.